Welcome to our dedicated page for Celestica SEC filings (Ticker: CLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Celestica Inc. (CLS) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations, governance and financial performance. As an Ontario, Canada corporation with common shares listed on the New York Stock Exchange, Celestica submits reports under the Exchange Act, including current reports on Form 8-K that disclose material events.
Recent Form 8-K filings illustrate the types of information investors can expect. Celestica has reported quarterly financial results and related conference calls, furnished press releases as exhibits, and described its guidance and outlook for revenue, adjusted operating margin, adjusted EPS and non-GAAP free cash flow. Other 8-Ks detail corporate actions such as the launch and acceptance of a normal course issuer bid on the Toronto Stock Exchange to repurchase a portion of its public float, with information on the maximum number of shares, timing and cancellation of repurchased shares.
The company’s filings also cover governance and Board matters. Examples include the appointment of new independent directors, committee assignments, and planned transitions such as the resignation of a director and the designation of a new Audit Committee Chair. These disclosures provide transparency into Celestica’s oversight structure and the experience of its Board members.
Through this SEC filings page on Stock Titan, users can access Celestica’s regulatory documents as they are made available on EDGAR. AI-powered summaries help explain key points from lengthy filings, including financial results, segment commentary for Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS), capital allocation decisions like issuer bids, and changes in corporate governance. Investors can also review insider and executive-related disclosures contained in applicable forms to better understand leadership and oversight at Celestica.
Celestica Inc. announced that Dr. Luis Müller plans to resign from its Board of Directors, including his roles as Chair of the Audit Committee and member of other board committees, effective at the conclusion of the regularly scheduled meeting on January 28, 2026. The company states that his decision is for personal reasons related to other professional commitments and not due to any disagreement with Celestica regarding its operations, policies, or practices.
To ensure continuity in oversight, the Board has appointed current director Amar Maletira to become Chair of the Audit Committee effective upon Dr. Müller’s resignation. Maletira brings over 25 years of public company business, strategic, and finance leadership experience, including multiple Chief Financial Officer roles, and has been determined by the Board to possess the financial expertise appropriate for this key governance position.
Celestica Inc. (CLS) Chief Legal Officer filed an amended Form 4 to report an equity award. On February 4, 2025, the reporting person received 2,317 restricted share units (RSUs), each representing a right to one common share or cash of equal value at the holder's election. These RSUs vest in two equal installments on February 4, 2026 and February 4, 2027. The amendment corrects the earliest transaction date and adds this previously omitted RSU grant, while all other information from the original filing remains unchanged.
Celestica Inc. Chief Financial Officer insider activity shows routine equity compensation events reported on a Form 4. On 12/01/2025, the CFO acquired 20,408 common shares through the vesting and settlement of previously granted restricted share units at an exercise price of $0. On the same date, 10,925 common shares were disposed of at $344.41 per share to cover tax withholding obligations arising from the RSU vesting, leaving the reporting person with 9,483 common shares held directly.
The derivative table shows 20,408 restricted share units exercised into common shares, reducing the reporting person’s RSU balance to zero for that grant. The filing notes that each RSU represents a contingent right to receive one common share or an equivalent cash amount, and that the original grant of 61,224 RSUs from 01/31/2023 vests in three installments over a three-year period.
Celestica Inc.'s Chief Human Resources Officer reported several equity transactions in company common shares on 12/01/2025. The officer acquired 6,802 common shares at an exercise price of $0 through the vesting and settlement of restricted share units (RSUs), increasing directly held shares before subsequent transactions.
To cover tax withholding arising from the RSU vesting, 3,642 shares were withheld and disposed of at $323.38 per share, and an additional 3,160 shares were sold at the same price. After these transactions, the officer directly owned 13,892 common shares and held no remaining RSUs from this grant.
Celestica Inc. reported an insider equity transaction by its President. On 12/01/2025, the officer acquired 17,792 common shares through the vesting and settlement of restricted share units at an exercise price of $0, increasing directly held shares. On the same date, 8,248 common shares were disposed of at $344.41 per share to cover tax withholding obligations tied to the RSU vesting. Following these transactions, the officer directly owned 108,970 common shares. The underlying RSU award covered 17,792 common shares and was fully settled, leaving no derivative securities from that grant outstanding.
Celestica Inc. Chief Operations Officer reports RSU vesting, tax withholding, and share sale. On 12/01/2025, 17,792 common shares were acquired at an exercise price of $0 upon the vesting and settlement of restricted share units (RSUs). On the same date, 8,605 of these shares were disposed of at $323.38 per share to cover tax withholding obligations, and 9,187 shares were sold in a market transaction at $323.38 per share, leaving 0 common shares held directly after these transactions.
These activities relate to an RSU grant of 53,375 units awarded on January 31, 2023, which vests ratably over three years, including on December 1 following the second anniversary of the grant date. Each RSU represents a contingent right to receive one common share or an equivalent cash amount at the holder’s election.
Celestica Inc. insider plans to sell common shares under Rule 144. A notice reports a proposed sale of 3,160 common shares through broker Canaccord Genuity on the NYSE, with an aggregate market value of 1,088,335.60. The filing notes that 115,036,621 shares of the issuer were outstanding. The shares to be sold were acquired on 12/01/2025 through the vesting of restricted share units from Celestica Inc., with the same date listed for acquisition and payment.
Celestica Inc. insider filed a Form 144 notice to sell up to 9,186 common shares through broker Canaccord Genuity on the NYSE, with an approximate sale date of 12/01/2025. The filing lists an aggregate market value of these shares of $3,163,750.26. The 9,186 shares were acquired on 12/01/2025 through restricted share unit vesting from Celestica Inc. Shares outstanding were 115,036,621 at the time referenced, providing context for the size of this planned sale.
Celestica (CLS) reported a director’s open‑market purchases on 10/30/2025. The filing lists four buy transactions totaling 6,000 common shares, at weighted average prices of $339.68 (700 shares), $340.55 (600), $341.96 (3,227), and $342.44 (1,473). Following these trades, the director beneficially owns 6,000 shares, held directly. No derivative securities were reported.
Celestica Inc. (CLS) announced final acceptance from the Toronto Stock Exchange for a normal course issuer bid to repurchase up to 5,722,527 common shares, representing approximately 5 percent of the outstanding public float as of October 20, 2025. The NCIB will run from November 3, 2025 to November 2, 2026. The company furnished the related press release as Exhibit 99.1.
FAQ
What is the current stock price of Celestica (CLS)?
What is the market cap of Celestica (CLS)?
